S6.14.3 – Louise and Roger React to Empowered SLD Patient Advocates
After the roundtable, Louise Campbell and Roger Green share their reactions to the enthusiastic, empowered advocates who are the Harrison Fellows.
October 9, 2025
After the roundtable, Louise Campbell and Roger Green share their reactions to the enthusiastic, empowered advocates who are the Harrison Fellows.
In this conversation, the organizers of the Stephen A. Harrison Patient Advocacy Fellowship Program discuss their goals for the program.
In this conversation, we learn about how the Stephen A. Harrison Patient Advocacy Fellowship Program started and meet the program organizers and five of the initial Fellows.
Louise Campbell and Roger Green interview Wayne Eskridge and Elena Samsonova of the Fatty Liver Foundation and five of the first class of Harrison fellows about the new Dr. Stephen A. Harrison Patient Advocacy Fellowship program.
Behavioral Change consultant Dr. Kristina Curtis joins Jörn, Louise and Roger to discuss the unique challenges associated with weight loss through dieting and nutrition and ways government can support this effort.
Dr. Kristina Curtis joins Jörn Schattenberg, Louise Campbell and Roger Green to wrap up the Steatotic Think-Thank on SLD, Mike Betel shares lessons from his 30-day Glucose Challenge, and Naim Alkhouri remembers Stephen Harrison while sharing his vision for the future of clinical trials and medical education.
This diverse episode includes a discussion of effective behavioral therapies, a look at drug development we did not discuss in prior episodes, and a sober discussion on how to do our best in addressing the important Washington Challenges under Trump and RFK Jr.
This week’s Newsmaker is Dutch Liver Patients Association President Jose Willemse. She discusses the patient screening program at the EASL Congress 2025 and the general idea of patient-sensitive dialogue with treaters.
This week’s Newsmaker is Mike Betel, Founder of the Fatty Liver Alliance. He discusses some of the reasons that key MASLD Patient Advocates like himself are getting more visibility at a broader swath of global conferences and the messages he delivers at the conferences he attends.
SurfingMASH concludes its coverage of the Emerging Trends Conference looking at an encouraging future in MASLD drug development and increasing interest in patient advocacy.